Table 4.
Actinobacteria.
| Reference | [42] | [43] | [34] | [35] | [36] | [37] | [38] | [39] | [40] | [41] |
|---|---|---|---|---|---|---|---|---|---|---|
| Taxa/Method | YF | PR | Ill Miseq | Ill Hiseq | Ro | |||||
| Unspec | < | |||||||||
| Bifidobacteriaceae, Unspec. | < | |||||||||
| Bifidobacteriaceae, Bifidobacterium | < | < | < | |||||||
| Coriobacteriaceae, Unspec | < | |||||||||
This table shows the significant relative changes in Actinobacteria between PD patients (PD) and healthy controls (HC), that were assessed by the 10 summarized Parkinson’s disease studies. < symbolizes a lower abundance in HC when compared to PD; Empty cells symbolize, that no significant change in PD compared to HC was found with the chosen methodological approach.The methods used by the studies are Yakult Intestinal Flora-SCAN (YF), 96-well block of the ABI PRISM 7900HT Sequence Detection System (PR), Illumina Miseq sequencing (Ill Miseq), Illumina Hiseq sequencing (Ill Hiseq), Roche 454 GS FLX Titanium sequencing (Ro).